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Résumé : 
Les nanomatériaux représentent un domaine de recherche actif mais aussi un secteur économique en 
pleine expansion en vue de nombreuses applications. Par exemple la production française pour les 
matériaux les plus courants (comme la silice, le dioxyde de titane, le noir de carbone) se chiffre en 
centaines de milliers de tonnes. Comme c’est le cas pour toute innovation, il convient de s’interroger 
sur les risques et, si nécessaire, de fixer des règles pour protéger la santé du consommateur et celle 
du travailleur. On discute en particulier les difficultés pour définir ces matériaux, de l’état des 
connaissances en matière de toxicité humaine ou environnementale et des prescriptions des agences 
en matière de sécurité.  
 
 
Abstract: 
Nanomaterials are an active area of research but also an economic sector in full expansion which 
addresses many applications domains. For instance, french production for the most common 
nanomaterials (such as silica, titanium dioxide, carbon black) is in the hundreds of thousands of tons. 
As for any innovation, one must consider the risks and, if necessary, establish rules to protect 
consumer health and that of the worker. This paper addresses in particular difficulties in defining 
these materials, the state of knowledge on human or environmental toxicity and requirements and 
agencies in charge of safety. 
 
 
 
 
I. Introduction 
Nanomaterials and nano-manufactured goods represent areas of scientific research and 
industrial applications in full expansion. They are already an industrial and economic reality. As for 
other industrial sectors, the introduction of these new products should be considered in terms of 
potential effects of toxicity and ecotoxicity, so to measure and to control as well the societal 
consequences that environmental and health. 
 
2 Definition of the perimeter of nanomaterials 
To define the concept of nanoparticles and nanomaterials and/or, it took until the pre - 
normative terminology such as defined by the ISO1 published at the end of September 2008 under the 
number ISO / TS 276872 ("Nanotechnology - terminology and definitions for the “nano-objects", i.e. 
Nanoparticle, nanofiber and nanoplate"), namely : 
(i) nano-definition considered the range of dimension between 1 and 100 nm. 
(ii) nano - objects are materials with one, two or three external in the nano-domain dimensions. 
Among these nano-objects, nanoparticles include their three dimensions in the field of nano, 
nano - plates have one nano-sized dimension, nanofibers are nano - objects with two nano-
sized dimensions, the third dimension being significantly longer. 
 
The 2009’s and 2010’s can be considered as very important concerning the definition of the 
field of nanomaterials and/or nanoparticles. They are indeed reflected by various national bodies. 
 
Thus, "Health Canada" (Ministry of Health in Canada) introduced a draft definition of the 
nanomaterials3. "Any manufactured product, material, substance, device, system or structure should 
be regarded as nanomaterials." 
i) If it is at the nanoscale, or within it, in at least one dimension space, 
ii)  If it is smaller or larger than the nanoscale in all dimensions and displays a nano-scale 
phenomenon or more. 
Health Canada States that the “nano-scale" means 1 to 100 nanometers, i.e. promoting ISO definition. 
However, two specific concepts are added. First of all, that of nano-scale phenomena which are 
“attributable to its size and distinguishable from the chemical or physical properties of individual 
atoms, individual molecules and bulk material”. 
On the other hand, "Health Canada" distinguished manufactured goods stating “the term 
"manufactured includes those technical processes and controls of matter and processes at the 
nanoscale”. 
 
Similarly, the NICNAS (The National Industrial Chemicals Notifications and Assessment 
Scheme is the Australian Government regulatory scheme for industrial chemical) defines the scope 
nano for entry into force on 1 January 20114 "... industrial materials intentionally produced, 
manufactured, modified to have unique properties or a specific nano-scale structure.", i.e. between 1 
and 100 nanometers, and that is either a nano object (i.e. confined to this scale in one, two or three 
dimensions) or nanostructured (i.e. with an internal structure or surface at this scale). Once again, the 
                                                            
1 ISO : International Standard Organisation 
2 http://www.iso.org/iso/catalogue_detail?csnumber=44278 
3 “Interim Policy Statement on Health Canada's Working Definition for Nanomaterials”- http://www.hc-sc.gc.ca/sr-
sr/consult/_2010/nanomater/draft-ebauche-eng.php 
4 “Adjustments to NICNAS new chemicals processes for industrial nanomaterials” 
http://www.nicnas.gov.au/Publications/Chemical_Gazette/pdf/2010oct_whole.pdf#page=14 
1-100 nm scale advocated by ISO is used. The NICNAS has the same concerns as Health-Canada. 
First it distinguishes materials intentionally produced, manufactured or modified from those produced 
accidentally. Second, it puts forward the ability of these objects to exhibit unique properties not found 
in the same non-nanostructured material.  
In addition, the NICNAS takes into account two extensions of the nano field: On the one hand 
aggregates or agglomerated materials are considered as nanostructured. On the other hand all 
materials of which the size of components distribution contains at least 10% of nano-scale particles 
are considered as nanomaterials. 
 
In October 2010, the European commission launches a consultation5 on the definition of 
Nanomaterials and, on this occasion, proposes a recommendation6:”Member States, the European 
agencies and industry are invited to use this definition of nanomaterial when they adopt and 
implement of regulations or programs relating to the products of nanotechnologies”. 
 
“ Nanomaterial: means a material that meets at least one of the following criteria: 
- consists of particles, with one or more external dimensions in the size range 1 nm - 100 nm 
for more than 1 % of their number size distribution; 
- has internal or surface structures in one or more dimensions in the size range 1 nm- 100 nm; 
- has a specific surface area by volume greater than 60 m2/cm3, excluding materials consisting 
of particles with a size lower than 1 nm”. 
 
The reading of these proposals for definitions - some even to the status of "draft" or simple 
recommendation - translates very clearly the taken into account by the authorities in charge of the 
framework for the development of these industrial sectors, of the specificities of nanomaterials, 
namely: the variation of physico-chemical properties, the importance of specific surface area, and the 
integration of the concept of size distribution of nanoparticles with consideration of a minimum 
content from which a product / component or a substance should be considered as falling within the 
field "nano". It should be noted the difficulty, for definitions and/or regulations, to define precise 
bounds in terms of dimensions for the field "nano". Thus, the dimensional limits 1 nm and 100 nm can 
be strict and exclusive or indicative. 
 
In addition to these attempts of definition, some almost entered the common language. By 
extension (and without doubt, abuse of language with respect to this definition), it is very often 
customary to extend the notion of nanoparticles to the whole of the nano - objects, while disregarding 
the number of dimensions of the object below 100 nm. Moreover, in this review, nanomaterials are to 
                                                            
5 http://ec.europa.eu/environment/consultations/nanomaterials.htm 
6 http://ec.europa.eu/environment/consultations/pdf/recommendation_nano.pdf 
be regarded as a more or less compact and dense assembly of nano - objects (aggregates and / or 
agglomerates). 
 
3 State of industrial production and fields of applications 
3.1. State of the production 
The extremely rapid development of nanomaterials and manufactured nanoparticles involves 
potential exposure to manufactured nanomaterials of a more and more significant population, in 
particular industrial operators (near 3270 staffs in France for the production) or research staff 
laboratories (approximately 7000 staffs in France). 
 
With regard to French industrial production of nanomaterials, the conclusion of a study7 
published in July 2008 by the French Agency for sanitary security of the environment and the 
workplace (AFSSET, which in the meantime became  the ANSES  i.e. the  national agency for sanitary 
security), relying on a previous study8 of the National Institute for research and safety (INRS) 
indicates the following annual productions in France: 
- About 485.000 tons of silica by approximately 1300 operators9, 
- 469.000 tons of alumina by nearly 1,000 operators, 
- 300,000 tons of calcium carbonate, 
- 240.000 tons of black carbon by 280 operators, 
-250,000 tons form sub - micronic titanium dioxide and 10,000 tons as nanoparticles involving 
270 operators, 
-The annual French production capacity of carbon nanotubes is 10 tons involving 10 operators. 
 
These figures for French production can be compared to the amount of these nanoparticles in 
the natural state. According to an article by Buzea and al.10 anthropogenic aerosols (i.e. due to human 
activity) represent only 10% of the total of these nanoparticles in the atmosphere. The annual source, 
of naturally occurring nanoparticles worldwide is estimated to about 16.8 million tons for mineral 
aerosol due mainly to wind erosion. Note that 1% of mineral aerosol is produced in volcanic eruptions. 
To these mineral aerosols, one should add 3.6 million tons of marine salts and 1.8 million tons of 
nanoparticles from biomass. 
 
                                                            
7 "Nanomatériaux et Sécurité au Travail", published in July 2008 
http://www.afsset.fr/upload/bibliotheque/258113599692706655310496991596/afsset-nanomateriaux-2-avis-
rapport-annexes-vdef.pdf 
8 "Production et utilisation industrielle des particules nanostructurées" 
HST ND 2277 - 209 – 07, paru en 2007 - Bertrand Honnert, Raymond Vincent 
http://www.inrs.fr/inrs-pub/inrs01.nsf/IntranetObject-accesParReference/ND%202277/$File/ND2277.pdf 
9 Operators means the people how are potentially exposed at workplace 
10 “Nanomaterials and nanoparticles: Sources and toxicity” 
C. Buzea, I.. I. Pacheco Blandino, K. Robbie  - Biointerphases, vol. 2, issue 4 (2007) pages MR17 - MR172 
The annual tonnage of sulphate of natural and anthropogenic origins is 3.3 millions tons. 
Industrial soot represents nearly 1.4 million tons. Nanoparticles of hydrocarbons (non-methane) are 
issued at a rate of 1.3 million tons per year. The annual tonnage of nitrate of natural and 
anthropogenic origins is 0.6 million ton. The tonnage of nanoparticles resulting of the natural process 
of degradation of biological organisms is also estimated to 0.6 million ton. Finally, these tonnages 
must be added to nearly 20,000 tons of cosmic dust 
 
The importance of these non-anthropogenic emissions of nanoparticles should be noted 
because they come to constitute natural background noise, which we need to extract it to get the 
content of manufactured nanoparticles. 
 
3.2. Scope of Applications 
The applications of nanomaterials are multiple, as developed following according to the report 
entitled "Prospective study on nanomaterials", carried out on behalf of the Directorate General of 
industry, technologies of information and the Department of Finance (DIGITIP) positions by French 
development & Council (2004)11. 
                                                            
11 "Etude prospective sur les Nanomatériaux" 
http://www.industrie.gouv.fr/enjeux/pdf/synthesenanomateriaux.pdf 
 
Nanomaterials Application fields
Nanoceramics Structural composite materials - components anti - UV - polishing substrates 
(wafers) in microelectronics Chemical - photocatalytical applications 
Nanometallics  Antimicrobial and/or sector of catalysis - conductive layers of screens, sensors 
or energetic materials. 
Nanoporous  Aerogels for thermal insulation in the areas of electronics, optics and catalysis -
bio - medical field for tracing or even implants type applications. 
Nanotubes Electrical conductive nanocomposites - structural materials - single-walled 
nanotubes for applications in the field of electronics, screens 
Massive 
Nanomaterials  
Hard coatings - structural components for the aerospace industry, automotive, 
pipes for oil and gas, sport or even anticorrosion sector industries. 
Dendrimers Medical field (administration of drugs, rapid detection) - domain cosmetic.
Quantum Dots Optoelectronics (screens) - photovoltaic cells - inks and paints for applications 
of type marking anti - counterfeiting 
Fullerenes  Sport (nanocomposites) and cosmetics sectors
Nanowires  Applications in the conductive layers of screens or even solar cells and 
electronic devices 
 
Table 1: Fields of applications by type of nanomaterials 
 
In the food sector, the National Agency for Sanitary Security - France (ANSES – Agence 
Nationale de Sécurité Sanitaire) has included in a report published in 201012, a case study of the use 
of silica nano as anti-caking for powdered sugar. A recent study by the National Institute for public 
health and the environment, the equivalent of the ANSES to the Netherlands allows to grasp 
concretely the magnitude of the very broad use of nanoparticles in silica as additives in non-negligible 
percentages, for example for type anti-caking applications, anti - agglomerating or even as a viscosity 
modifier: sauce for lasagna, instant noodles, various seasoning for meat and burrito, pancake, pepper, 
coffee cream, roasted vegetables, lasagna sauce mix13. 
 
                                                            
12 "Les Nanomatériaux : Évaluation des risques liés aux nanomatériaux pour la population générale et dans 
l'environnement" - Saisine Afsset n° 2008/005" 
F. Nesslany, M. Boize, J.-Y. Bottero, D. Chevalier, E. Gaffet, O. Le Bihan, C. Mouneyrac, M. Riediker, F. Tardif - 
Rapport Agence Française de Sécurité Sanitaire, de l’Environnement et du Travail, Mars 2010. 
http://lesrapports.ladocumentationfrancaise.fr/BRP/104000168/0000.pdf 
13 “Presence and risks of nanosilica in food products” 
S. Dekkers, P. Krystek, R. J.B. Peters, D. P.K. Lankveld, B.G.H. Bokkers, P.H. Van Hoeven-Arentzen, H. 
Bouwmbester, A.G. Oomen - Nanotoxicology J 2010; Early Online J 1-13 
 
4 State of toxicity and EcoToxicité knowledge 
The State of knowledge on the effects of micro/nano particles atmospheric pollution makes 
fear effects on health of man - produced14,15 nanoparticles. Nevertheless, very little reliable data - in 
the sense of reproduced by different research teams - are currently available in this area. However 
the published studies which report interactions of nanoparticles with the living at the cellular level, 
encourage caution16. 
 
In the field of toxicology  and/or eco - toxicology research, the effects of particles are deemed 
be correlated to the mass of product to which animals or humans are exposed: the greater the 
absorbed mass, the greater is the effect. 
 
In the case of nanoparticles, it has been clearly demonstrated17,18,19 that the mass of the 
product is not the most relevant parameter to correlate with measured effects, thus upsetting the 
traditional interpretation of the measures of toxicity. It is indeed found, that equal mass, nanoparticles 
are more toxic that the products of the same chemical composition presented in fragments of larger 
size. 
 
Although several studies have found a correlation between the specific surface area and the 
toxicity, there seems to be a consensus in the scientific community to agree that several factors 
contribute to the toxicity of these new generation products and that it is currently impossible, from 
our fragmentary knowledge, to balance their respective weight or accurately predict the toxicity of a 
new nanoparticle. Published studies link observed effects which are due to different parameters : 
specific surface area, number of particles20, size and size distribution, concentration, surface state21 
(contamination, electric charge), degree of particle agglomeration and site of deposition in the lungs22, 
                                                            
14 “Characteristics of a Residential and Working Community With Diverse Exposure to World Trade Center Dust, 
Gas, and Fumes” J. Reibman, M. Liu, Q. Cheng, MS, S. Liautaud, L. Rogers, S. Lau, K. I. Berger, R. M. Goldring, 
M.l Marmor, M. E. Fernandez-Beros, E. S. Tonorezos, C. E. Caplan-Shaw, J. Gonzalez, J. Filner, D. Walter,, K. 
Kyng, W. N. Rom - J Occup Environ Med. 2009 May; 51(5): 534– 541. 
15 “A review of commuter exposure to ultrafine particles and its health effects” 
L. D. Knibbs , T. Cole-Hunter L. Morawska - Atmospheric Environment 45 (2011) 2611e2622 
16 "Les Nanoparticules. Un enjeu majeur pour la santé au travail ?" 
sous la direction de Benoit Hervé – Bazin (INRS), EDP Sciences 2007 
17 “Airborne nanostructured particles and occupational health” 
A. D. Maynard, E. D. Kuempel - Journal of Nanoparticle Research (2005) 7: 587–614 
18 “Airborne nanostructured particles and occupational health” 
G. Oberdörster, E. Oberdörster, J. Oberdörster - Environ Health Perspect. 2005 Jul;113(7):823-39 
19 “Concepts of nanoparticle dose metric and response metric” 
G. Oberdörster, E. Oberdörster, J. Oberdörster- Environ Health Perspect. 2007 June; 115(6): A290 
20 “In search of the most relevant parameter for quantifying lung inflammatory response to nanoparticle 
exposure: particle number, surface area, or what?” 
K. Wittmaack.- Environ Health Perspect. 2007 Feb;115(2):187-94 
21 “Skin penetration and kinetics of pristine fullerenes (C60) topically exposed in industrial organic solvents” 
Xin R. Xia, Nancy A. Monteiro‐Riviere, Jim E. Riviere ‐ Toxicology and Applied Pharmacology 242 (2010) 29–37 
22 “Quantitative biokinetic analysis of radioactively labelled, inhaled Titanium dioxide Nanoparticles in a rat model” 
W. G. Kreyling A. Wenk, M. Semmler-Behnke - http://www.umweltdaten.de/publikationen/fpdf-l/4022.pdf  
the surface electrical charge, shape, porosity, crystalline structure, the potential of electrostatic 
attraction, method for particle synthesis, hydrophilic/hydrophobic character and post-synthesis 
modifications (the surface coating to prevent agglomeration). The presence of contaminants such as 
metals can also promote the formation of free radicals and inflammation. Similarly the particle 
chemical composition and leaching in the body of components present on its surface, the colloidal 
properties and surface of nanoparticles, compartmentalization in the respiratory tract and the bio - 
persistence are factors rendering more complex the understanding of their toxicity. In addition, the 
slow dissolution of some of nanoparticles or some of their components in the body may become a 
major element determining their toxicity. These factors will therefore influence their functional, 
toxicological and environmental impact. 
 
The toxicological effects of nanomaterials began to be investigated in recent years on animal 
models and cell culture. There are almost no studies on toxicological effects of nanomaterials for 
humans. Due to the small number of studies, the advent of recent nanomaterials and their variability, 
interpretation of experimental studies on the effects of nanomaterials requires great caution. 
 
Among various mechanisms envisaged to understand specific toxicity of nanoparticles, a 
recent publication describes mainly two major types of mechanisms23 as being at the origin of the 
toxicological effects of nanomaterials: 
(i) oxidative stress induction: metal nanomaterials can produce significant quantities of reactive 
forms of oxygen (still called free radicals) on their surface or induce their excessive production 
by cells. These molecules are of a high biological reactivity, and can damage the walls of the 
cells, which can induce reactions of inflammation, and fibrosis. They can also adversely affect 
the DNA of cells and favor cancerous process. 
(ii) surface adsorption of biologically active molecules:, because of their specific surface properties, 
nanomaterials may adsorb biologically active molecules, as factors required for cell growth, thus 
inducing cell suffering and sometimes death, be nanoparticles internalized in cells or not24. 
These effects have been well documented for the lung case25. Moreover, according to studies 
with animal models, exposure to some particular carbon nanotubes can induce damage similar 
to those induced by asbestos2627. 
                                                            
23 "Nanoparticules : une prévention est-elle possible ? - Nanoparticles : Is a prevention possible?" 
J. Boczkowski, S. Lanone - Revue française d’allergologie Volume 50, numéro 3 pages 214-216 (avril 2010) 
24 “Engineered nanoparticles Rev Health Environmental Safety” 
Aitken R, Aschberger K, Baun A, Christensen F, Fernandes TF, Hansen S, Hartmann N, Hutchison G, 
Johnston H, Micheletti C- Enrhes (2010) 
25 “Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes : two faces of janus ?” 
Shvedova AA, Kisin ER, Porter D, Schulte P, Kagan VE, Fadeel B, Castranova V. Pharmacol Ther 2009; 121 : 192- 
204.] 
26 "Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube" 
Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, et al.. J Toxicol Sci 2008; 33: 105-16, 
27 “Carbon nanotubes introduced into the abdominal cavity of mice show asbestoslike pathogenicity in a pilot 
study”  
 For animals, as a consequence of the two mechanisms described above by S Lanone and J. 
Boczkowski, several effects have already been demonstrated including toxic effects for various organs 
(heart, lungs, kidneys, reproducing organs…), as well as genotoxcity2829 (DNA damage) and 
cytotoxicity (cell toxicity)30. Some particles, for example, cause granulomas, fibrosis and tumor 
reactions at chest level. Thus a substance reputed to be little harmful, titanium dioxide, exhibits 
significant pulmonary toxicity when it is nano-sized. 
 
Overall, nanoparticle-specific toxicological data remain limited. Beyond very partial data, 
quantitative assessment of risk is difficult for most substances, in particular because of short periods 
of exposure, of various compositions of tested nanoparticles (diameter, length and agglomeration). in 
addition the route of exposure used for toxicity assessments is often not representative of 
occupational exposure. Additional studies (absorption, bio - persistence, carcinogenicity, translocation 
to other tissues or organs, accumulation, etc.) are therefore needed to dispose of all of the 
information required for the quantitative assessment of the risk associated with exposure by 
inhalation, percutaneous exposure among workers. Available data clearly indicate that certain 
insoluble nanoparticles can cross different biological protection barriers, to disseminate inside the 
body and accumulate in some organs and cells. Toxic effects have already been documented for 
lungs, heart, reproductive system, kidney, skin and at cellular level. Significant accumulations were 
reported in lungs, brain, liver, spleen, and bone. Among biological barriers which nanoparticles cross 
easily, the placental barrier31,32 should be noted  
 
In the light of this brief summary, embodying the elements of a synthesis of the work of 
literature synthesis published by the Institut de Recherche Robert-Sauvé in health and safety at 
workplace in Quebec (IRSST) in April 200833 or those from a australian study34, major trends are 
emerging and reveal many toxic effects related to certain nanoparticles. 
                                                                                                                                                                                         
C. A. Poland, R. Duffin, I. Kinloch, A. Maynard, W. A. H. Wallace, A. Seaton, V. Stones, S. Brown, W. Macnee, K. 
Donaldson, Nature Nanotechnology, Published online: 20 May 2008; doi:10.1038/nnano.2008.111] 
28 “Titanium Dioxide Nanoparticles Induce DNA Damage and Genetic Instability In vivo in Mice” 
B. Trouiller, R. Reliene1, A. Westbrook, P. Solaimani1, R. H. Schiestl - Cancer 
29 “Nanoparticles can cause DNA damage across a cellular barrier” 
G. Bhabra, A. Sood, B. Fisher, L. Cartwright, M. Saunders, W. H. Evans, A. Surprenant, G. Lopez- Castejon, S. 
Mann, S. A. Davis, L. A. Hails, E. Ingham, P. Verkade, J. Lane, K. Heesom, R. Newson, C. P. Case 
Nature Nanotechnology 4, 876 - 883 (2009) 
30 “SiO2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells” 
X. Yang, J. Liu, H. He, L. Zhou, C. Gong, X. Wang, L. Yang, J. Yuan, H. Huang, L. He, B. Zhang - 
Particle and Fibre Toxicology, 2009, 7: 1 (42pp) 
31 “Transfer of Quantum Dots from Pregnant Mice to Pups Across the Placental Barrier“ 
M. Chu, Q. Wu , H. Yang, R. Yuan, S. Hou, Y. Yang, Y. Zou, S. Xu, K. Xu, A. Ji, L. Sheng - Small – 2010 Volume 6 
Issue 5, Pages 670 - 678 
32 “Effects of prenatal exposure to surface-coated nanosized titanium dioxide (UV-Titan). A study in mice” 
K. S Hougaard, P. Jackson, K. A Jensen; J. J Sloth, K. Loschner , E. H Larsen, R. K Birkedal, A. Vibenhol , AM Z 
Boisen, H. Wallin, U. Vogel ‐ Particle and Fibre Toxicology 2010, 7:16 doi:10.1186/1743‐8977‐7‐16 
33 "Les effets sur la santé reliés aux nanoparticules, seconde édition" 
 It is clear that each synthesized product can have its own toxicity. This implies then studies 
"on a case by case" basis, and especially very great caution in extrapolating, or even generalizing the 
results of tests on one or other of various nanoparticles to all for example the same chemical 
composition or same dimension nanoparticles. 
 
On the basis of the work published to date, it seems indeed that any modification of the 
process used to produce a given nanoparticle or to modify its surface could have an impact on its 
toxicity. Here, it should be noted that changes of surface properties for a given particle type will 
depend on the life cycle of the material. Consider the example of titanium dioxide. It is exposed to 
different environments (hence to different contaminant) depending on its implementation in a solar 
cream, embedded in a varnish or introduced into concrete. 
 
This analysis of the IRSST is also supported by a journal article by Hansen et al.35 on the basis 
of the analyses of 428 published studies about 965 nanoparticle toxic effects, it appears that on these 
428 studies, 120 indicate a specific toxicity in mammals and 270 a cytotoxicity in "in vitro" 
experiments. The journal article highlights also the variability of nanomaterials to be considered and 
little information actually available (and relevant) on the nature of nanoparticles studied. 
 
This observation of the importance of the variability of physic-chemical parameters on the 
results of the tests to study the toxicity and ecotoxicity of these nanoparticles led the Working Party 
on Manufactured NanoMaterials (WPMN) work carried out at the level of the OECD to clarify the 
critical parameters to set. Physico - chemical parameters and toxicity and ecotoxicity tests to perform 
to assess the dangerousness of nanoparticles are listed below. 
                                                                                                                                                                                         
 Études et recherches / Rapport R-558, Montréal, IRSST, paru en Avril 2008. 1) Claude Ostiguy, Brigitte Soucy, 
Gilles Lapointe, Catherine Woods et Luc Ménard http://www.irsst.qc.ca/files/documents/PubIRSST/R-558.pdf "Les 
nanoparticules : connaissances actuelles sur les risques et les mesures de prévention en santé et en sécurité du 
travail" and 2) Claude Ostiguy, Gilles Lapointe, Luc Ménard, Yves Cloutier, Mylène Trottier, Michel Boutin, Monty 
Antoun, Christian Normand Études et recherches / Rapport R-455, Montréal, IRSST, paru en 2006 
http://www.irsst.qc.ca/files/documents/PubIRSST/R-455.pd 
34 “Engineered Nanomaterials: A review of the toxicology and health hazards” 
Safe Work Australia (2009) – 
http://www.safeworkaustralia.gov.au/AboutSafeWorkAustralia/WhatWeDo/Publications/Documents/313/Engi 
neeredNanomaterials_%20Review_ToxicologyHealthHazards_2009_PDF.pdf 
35 “Categorization framework to aid hazard identification of nanomaterials” 
S. F. Hansen, B. H. Larsen, S. I. Olsen, A. Baun - Nanotoxicology, 1 ‐ 8 (2007) 
http://dx.doi.org/10.1080/17435390701727509 
 
Physical-Chemical Properties and Material 
Characterization 
• Agglomeration/aggregation  
• Water solubility  
• Crystalline phase 
• Dustiness  
• Crystallite size 
• Representative TEM picture(s) 
• Particle size distribution 
• Specific surface area 
• Zeta potential (surface charge) 
• Surface chemistry (where appropriate) 
• Photocatalytic activity  
• Pour density  
• Porosity  
• Octanol-water partition coefficient,  
• Redox potential  
• Radical formation potential  
• Other relevant information  
Environmental Fate  
• Dispersion stability in water 
• Biotic degradability  
• Ready biodegradability  
• Simulation testing on ultimate 
degradation in surface water 
• Soil simulation testing  
• Sediment simulation testing  
• Sewage treatment simulation testing  
• Identification of degradation product(s) 
• Further testing of degradation 
product(s) as required 
• Abiotic degradability and fate  
• Hydrolysis, for surface modified 
nanomaterials  
• Adsorption- desorption  
• Adsorption to soil or sediment 
• Bioaccumulation potential  
• Other relevant  
Environmental Toxicology  
• Effects on pelagic species  
• Effects on sediment species  
• Effects on soil  
• Effects on terrestrial species  
• Effects on microorganisms  
• Other relevant information  
Mammalian Toxicology  
• Pharmacokinetics (ADME) 
• Acute toxicity  
• Repeated dose toxicity  
If available: 
• Chronic toxicity  
• Reproductive toxicity  
• Developmental toxicity  
• Genetic toxicity  
• Experience with human exposure  
• Other relevant test data 
Material Safety  
Where available: 
• Flammability  
• Explosivity  
• Incompatibility  
 
 
Table 2: List of critical physico - chemical parameters and nature of tests to determine the 
dangerousness of nanoparticles of interest (OECD / WPMN)36 
 
As indicated in the IRSST 2008 report cited above, in the case of soluble nanoparticles, 
toxicity is related to their composition, regardless of their original size. After dissolution of the 
nanoparticles, toxicity is purely chemical origin. According to the same report, the situation is quite 
different for insoluble or very little soluble nanoparticles; size plays a role in this case. 
 
Data currently available on toxicity of insoluble nanoparticles are fragmentary and do not 
always allow  a quantitative risk assessment (or extrapolation to humans for nanoparticles synthesis), 
                                                            
36 “Series on the safety of manufactured nanomaterials number 6 list of manufactured nanomaterials and list of 
endpoints for phase one of the oecd testing programme”  ( ENV/JM/MONO(2008)13/REV (July 2008) - 
http://www.olis.oecd.org/olis/2008doc.nsf/LinkTo/NT000034C6/$FILE/JT03248749.PDF 
except perhaps for TiO37. Elements of knowledge on their impact on the environment are even more 
limited. These elements on the concept of bio - persistence of insoluble nanoparticles and their health 
impact remain to this day relatively little explored both on animal models and on the environment in 
the broad sense 
 
Given the importance and the activity in this area, various internet sites now allow the 
following of publications and other scientific work. This is the case for "The Virtual Journal on 
Nanotechnology, Environment, Health and Safety"38 maintained by Rice University in the United 
States.  
 
5 Ways to prevent 
Given these various findings and uncertainties about the health effects of nanoparticles, the 
AFSSET recommended in 2008 to declare nanoparticles as "level of unknown danger" and manipulate 
them with the same caution as hazardous materials, i.e. to apply the safety procedures which are 
implemented to reduce the exposure to hazardous materials. Of course, as noted by the IRSST in 
conclusion of its report, the risk assessment should also take account of the route of exposure, its 
duration and the nanoparticles concentration and the susceptibility of the individual as well as the 
interaction of particles with biological components and biological fate. 
The majority of the reports indicate that, given the lack of knowledge on the toxicity of 
nanoparticles, one is led to conclude that the risk control is based on the control of exposure. This 
point is developed in the next section which addresses the ways and methods of prevention i.e. "Nano 
- safety" as developed in the AFSSET 37 report. 
 
At this point, two opinions of the High Council for Public Health in France (HCSP – Haut 
Conseil de la Santé Publique) should be stressed : 
(i) The first one, which was published  in January 200939, deals with carbon nanotubes. It builds on 
the report of the group in charge of following up research on the health impact of nanotechnology 
(created by the HCSP in 2008), on the Afsset’s one (report of July 2008 quoted above), as well as on 
the advice40 of the Committee of prevention and precaution  published in May 2006. The High Council 
of public health says it considers the results of this expertise "as constituting a major warning sign for 
the rapid implementation of measures to protect against exposures that might induce a serious health 
risk for producers and users of carbon nanotubes." 
                                                            
37 “NIOSH CURRENT INTELLIGENCE BULLETIN: Evaluation of Health Hazard and Recommendations for 
Occupational Exposure to Titanium Dioxide”  
National Institute for Occupational Safety and Health, published in December 2005 
http://www.cdc.gov/niosh/review/public/Tio2/pdfs/TIO2Draft.pdf]. 
38 http://www.icon.rice.edu/virtualjournal.cfm 
39 "AVIS relatif à la sécurité des travailleurs lors de l’exposition aux nanotubes de carbone " 
HCSP - 7 janvier 
2009 - http://www.hcsp.fr/docspdf/avisrapports/hcspa20090107_ExpNanoCarbone.pdf 
40 "Nanotechnologies, nanoparticules. Quels dangers, quels risques ?" 
http://www.ladocumentationfrancaise.fr/rapports-publics/074000286/index.shtml 
The High Council of Public Health (France) noted that nanoparticles should be subject to a 
procedure for registration and evaluation as of new chemical substances in Europe. He recommends 
to apply the precautionary principle, with respect to carbon nanotubes, i.e., to ensure that their 
production and their use (including for research activity) are under strict confinement conditions. 
 
Moreover, the High Council of public health highlights the following actions it considers 
priority: 
1. Recommendations in terms of identification of situations of potential exposures and of nanosafety 
especially for carbon nanotubes: 
1.1 Identify and inventory worker populations likely to be exposed at each stage of the carbon 
nanotube lifecycle, in order to the implement their health surveillance. This provision will 
be facilitated by the duty of Declaration of use of nanoparticles that the HCSP wishes to be 
enacted, as expected, in the framework of the Grenelle act on environment, as well as by 
the duty of labeling products containing nanoparticles also provided for in this framework. 
1.2 Develop information of people affected by the risks and their prevention and associated 
training. These actions should particularly target the committees and the teams in charge 
of of occupational medicine. This means including the markup of the premises and / or the 
work stations affected by the use of carbon nanotubes (pictogram for nano-hazard) 
1.3 Include in the "safety" folder of any producer or user of carbon nanotubes a "nano-safety" 
component, which takes into account all of the life cycle of nanomaterials in the 
establishment, since their introduction in the workplace until their elimination. This 
provision should also apply to companies in charge of nanomaterial waste disposal. 
1.4 For substances containing carbon nanotubes, request that the safety data sheet explicitly 
mentions the presence of carbon nanotubes, as well as the need to implement 
precautionary practices. 
1.5 Organize traceability of exposure, through an individual exposure sheet as it is defined in 
the labor code, intended to be part of the medical record of each potentially exposed 
person. 
2 Recommendations for research on metrology and risks 
The High Council of public health recommends the development of a research priority in the 
following areas: 
2.1 Metrology of exposure to carbon nanotubes and other nanoparticles. As soon as possible it 
must be associated with the constitution a database about exposures. 
2.2 Evaluation and improvement of processes involving at different stages, carbon nanotubes 
and of collective and individual protection equipment.  
2.3 Constitution of a cohort of workers potentially exposed to nanoparticles, the priority being 
to this day to carry out a census of the people concerned and the compendium all relevant 
data to characterize their potential exposure.  
2.4 Development of biological indicators of exposure and markers for early effects, in order to 
allow, where appropriate, the implementation of adapted medical follow-up.  
2.5 Experimental toxicology for assessment of toxicity and carcinogenicity of nanotubes 
depending on the different routes of exposure. Currently, it is important to investigate the 
role of nanotube size, shape, rigidity and of the bio-persistence, including the translocation 
capability.  
 
More generally, the High Council of the public health, aware that nanoparticles exhibit a wide 
range of physico-chemical characteristics and therefore, presumably, also of toxicological 
properties, recommends that are strengthened vigilance and research the possible health 
effects of different forms of nanoparticles. 
 
(ii) Tthe second notice of the HCSP published in March 2010 focused on silver nanoparticles41. The 
specialized Commission for risks - environment (CSRE) of the High Council of public health, noting 
wew silver nano structural forms and their new uses in varous goods  and industrial applications, drew 
the attention of health authorities : 
1.  On the need to implement a monitoring of the use of silver nano device in goods, especially 
those who come directly into contact with the consumer. Such a provision would ensure the 
traceability and information on the presence of nano silver, from production to the placing on 
the market, the disposal or recycling. 
 This requires labelling of products and inventories (database) and must be accompanied by an 
assessment of the life cycle of the nano silver they contain. 
2.  On the need for research in particular on (i) the measurement of nano silver as well as its fate 
in food, water, air and (ii) a better understanding of its effects on man and the environment, 
including the consequences of the genotoxic and pro-apoptotic effects that it could lead to 
long term in connection with the different chemical structures of nano silver in consumer 
products. 
3.  On the importance of a toxicological and environmental assessment prior to introduction on 
the market for new products without waiting for implementation of EU regulation that French 
authorities are invited to promote, according to the founding principles of REACH and biocides 
regulations. 
 
The CSRE / HCSP invites health authorities to seize the competent health security agencies to 
ensure a scientific intelligence and an assessment of the risk. It declares itself ready, on this basis, to 
conduct an analysis on the options for risk management related to the use of nano silver in consumer 
                                                            
41 "Recommandation de vigilance relative à la sécurité des nanoparticules d’Argent" 
Haut Conseil de la Santé Publique- 12 mars 2010 
http://www.hcsp.fr/docspdf/avisrapports/hcspa20100312_nanoag.pdf 
products. More generally, it wishes risk/benefit assessments to be developed in the field of 
nanotechnologies applications leading to consumer’s exposure. 
 
5.1. Nano-safety (the so - called "STOP" principle) 
Developed and implemented means of prevention for nanoparticles follow the priority order 
classically used for chemical risk prevention. They rely on the STOP principle, as presented recently in 
the report of the AFSSET "Nanomaterials and occupational at worplace safety" published in July 2008. 
The principle is to apply hierarchical control strategies. Protective measures should be defined 
and if necessary adapted to the results of the risk assessment. The strategy for monitoring protective 
measures must follow the "STOP" principle (Substitution, Technologies, Organization, personal 
Protection). This acronym indicates the priority order for these four axes of control. The first choice is 
the Substitution, followed by the Technological measures and then of Organizational measures. The 
need for individual Protection should be avoided as much as possible. It applies only as an additional 
measure to reduce the risk, complementary to the other three strategies  
 
● Substitution 
Substition means: 
- Replace toxic substances (basic particle material) by less toxic substances, 
- Change the physical nature of the material, 
- Change the type of application: this approach relates to the replacement of an application in 
powder or liquid spray (aerosol formation) by an application in liquid phase, 
- Eliminate nanoparticles as soon as they are no longer necessary, 
- Optimize equipments and processes, 
- Favour forms which are non-dispersible in atmosphere, including suspensions in liquid or 
masters-mixtures. 
 
● Technologies 
This means implementing technical protection measures that are designed, as well as 
possible, to establish a barrier between workers and potentially dangerous substances or processes. 
Thus one effectively eliminates hazard exposure. The following approaches should be evaluated: 
- Use closed systems, 
- Use unbreakable containers or double containers for storage and transport, 
- Manufacture and use the substance on a form which limit its dispersion, 
- Capture pollutants at emitting source, 
- Air Filtering prior to release, 
- Separate work premises and adapt ventilation of the premises, 
- Waste. 
 
● Organization 
Organizational measures were designed to reduce as much as possible interactions of staff 
with nanomaterials. These include different elements such as the limitation of the number of persons 
entering areas with probable exposures. Personnel only required for the current task and who have 
completed a safety training can enter. The staff control is ensured by a badge or a similar system. 
Moreover personnel working in high risk areas must be monitored (for example with device like a 
dead man switch). In addition, specific prevention and protection techniques should be considerd 
when one handles nanoparticles presenting a special risk of ignition or explosive (for example nano 
carbon or nano aluminum). This requires in particular the signaling of the danger of the area. 
 
● Individual Protection 
The so-called protective measures are the last line of defense against the occupational 
hazards. They include generally special clothing, protection against inhalation (mask), possibly 
overpressure of external air at the production site, skin protection, eye protection, protection against 
ingestion. One must take into account that these protections are often discomfortable or even 
constitute a significant physical load. They are sometimes difficult to apply or to wear properly. 
Individual protection measures will be implemented only if all other measures are not sufficient to 
achieve a level of acceptable risk. In this case, individual protective measures are a complement (not 
replacement) of the other measures. 
 
5.2. Metrology - measurement and thresholds limits 
In order to assess the operator residual exposure to nanomaterials, one must measure the 
atmosphere of the premises or the personnel exposure, according to assessed hazards, using available 
instrumentation. Measurements must distinguish manufactured nanomaterials from ambient 
background noise (natural particles and other sources). In cases where some characterizations are 
technically impossible, samples may be taken following determined protocols to be analyzed later 
when technical means will be available. 
 
5.2.1. Means of action 
Equipments that can be used to characterize the staff exposure are described in the annex to 
the AFSSET report of July 2008. They are ranked by increasing selectivity to particles with respect to 
background noise. We first find devices which measures only the particulate concentration, therefore, 
without any selectivity. Then we find equipments measuring both concentration and size (they 
discriminate particles of interest if these differ by size from the backgroud ones), and finally specific 
measuring methods (discrimination by nanoparticles composition or shape). 
There is already a significant commercial offer to characterize the atmosphere of exposure to 
nanoparticles. These devices are based on principles of measurement sometimes very different: 
electric charge, scattered light, elementary mass, etc. that lead to different measurement 
methodologies from those listed above - before. 
In practice, however, note that it is not uncommon to obtain substantially different values of 
nanoparticles concentration for the same sample using two equipments yet based on the same 
principle. An important work of consolidation of the results obtained by the different methods of 
measurement and the development of simple calibration devices transportable is therefore necessary. 
This is the object of standardization work in the ISO context. 
 
5.2.2  Recommendations for thresholds limits 
In the particular case of carbon nanotubes, the National Institute for research and of security 
(INRS - France) stresses that the toxicological knowledge is still insufficient to establish values limits 
of occupational exposure to carbon nanotubes. He advocates that in the absence of limit value for 
exposure in French and European legislation,  level of exposure as low as possible must be sought 
In the case of TiO2 nanoparticles, in the United States, the National Institute for safety to the 
work and health (NIOSH), expressed a specific risk for nanoparticles of TiO2 proposing a threshold of 
0.1 mg/m3 for exposure value, i.e. a decrease by a factor of 15 with respect to the threshold value for 
micronic particles of the same compound. This threshold of 0.1 mg/m3 corresponds to approximately 
4.105 particles of 50 nm per cm3 of air or 5.104 particles of 100 nm per cm3. Thus, for a compound yet 
deemed to be weakly toxic in classical form, the proposed threshold corresponds to a number of 
nanoparticles that may be of the same order of magnitude as the background noise of natural 
particles. It is reasonable to think that even more severe thresholds will be awarded for more toxic 
nanoparticles than the TiO2 ones. 
 
The guide42 of good practices of the British Institute of Standardization (BSI) proposes four 
types of nanoparticles and limit values for exposure based on those established limits currently for the 
larger particles. In some cases, exposure limit values are set at a lower level, since a material in 
nanoscale form may be more dangerous than a microscale one. 
i) Fibrous materials : The BSI guide suggests as limit value exposure occupational fibers43 the value 
of 0.01 fiber/ml, counts being carried out in scanning or transmission electron microscopy. This value 
is identical to the legal value after an asbestos site (counting in optical contrast of phase microcopy). 
ii) Nanomaterials based on carcinogenic, mutagenic or toxic substances for the 
reproduction : Considering that, in nanoscale form, these materials may have a solubility and 
therefore an increased bioavailability, the guide suggests to adopt limit values for occupational 
exposure ten times lower than those in force now for these substances. 
iii) Insoluble nanomaterials : The BSI guide endorsed the NIOSH work and proposals for 
recommendations (it is for the time being that of a working document) about titanium dioxide i.e. 1.5 
                                                            
42 “Nanotechnologies – Part 1: Good practice guide for specifying manufactured nanomaterials” 
http://www.bsi-global.com/upload/Standards%20&%20Publications/Nanotechnologies/PD6699-1.pdf 
43 Defined by a length greater than 5 micrometers and a length/width ratio  > 3  
mg/m3 for fine particles but 0.1 mg/m3 for ultrafine ones. Although it has been noted above that 
concentrations expressed in terms of mass are not necessarily representative of toxic effects, it is 
used still, until that other methods of measurement to be validated. In the absence of other studies, 
the BSI proposes that a similar approach applies to other insoluble nanomaterials, weighting existing 
limit values for occupational exposure by a factor of 0.066 (i.e. as for titanium dioxide). Another 
proposal for a limit value is based on the fact that urban pollution in the UK reaches commonly values 
lying between 20 000 and 50 000 nanoparticles per milliliter. The lower limit of 20 000 particles by 
milliliter (distinguishing ambient pollution particles) could be a value reference appropriate for 
insoluble nanoparticles. 
iv) Soluble nanoparticles: for materials highly soluble regardless of their form, it is unlikely that 
nanoparticles present a superior bioavailability to those of larger particles. Similarly, it is unlikely they 
induce effects associated with insoluble nanoparticles. Therefore, it is proposed by the BSI to apply 
the values of occupational exposure limits a safety factor of 0.5. 
 
6 Conclusion 
All of the currently available studies, in vivo and in vitro, highlight the existence biological 
effects of nanomaterials in terms of inflammation, functional or structural, modulations at cellular level 
or for whole body.  However, little data are currently available, and it seems urgent to deepen existing 
knowledge on the mechanisms involved in the dispersal of nanomaterials in the body. The risk 
assessment must not only take into account the potential effects of native nanomaterials, but also 
their behaviors and all of their life cycle (mode of manufacture, use, aging, bio-degradability…). 
 
Moreover, it is essential to know levels and situations of exposure, and therefore the 
conditions of manufacture and composition of the products containing nanomaterials. In the absence 
of regulatory obligation, industrialists are very reluctant to communicate this information. In addition, 
epidemiological surveillance of workers exposed to nanomaterials should contribute decisively to the 
improvement of knowledge about their health effects possible medium and long-term. 
 
Nanoscience (nanotechnologies and/or nanomaterials) are already an industrial and economic 
reality. Like other industrial sectors, should be questioned the introduction of these new products to 
measure and to control the consequences both societal that environmental and health. It's a crucial 
issue for the responsible and secure development of nanomaterials and nanotechnology. 
